Fingerprint
Dive into the research topics of 'Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer
N. M. Tiffany, E. M. Wersinger, M. Garzotto, T. M. Beer
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations